CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

Updated report

Provides comprehensive understanding and unprecedented access to the  biomarker partnering agreements deals and agreements entered into by the worlds leading healthcare companies. More


Featured partnering deals

Zoetis acquires Abbott animal health assets

November 18, 2014 : Abbott, acquisition, asset purchase, big pharma, Zoetis

Zoetis announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million more »

Roche terminates interest in Inovio INO-5150 prostate cancer immunotherapy

November 18, 2014 : partnering, Roche, termination

Inovio Pharmaceuticals announced Roche have terminated their 2013 collaboration, option, and license agreement to co-develop INO-5150 more »

 More partnering deals | all deals at Deal Monitor

Featured M&A deals

Actavis agrees to acquire Allergan in $66 billion deal

November 18, 2014 : acquisition, Actavis, Allergan, big pharma, M&A

Actavis and Allergan have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock more »

Baring Asia acquires Bushu Pharmaceuticals

November 18, 2014 : acquisition, M&A

Baring Private Equity Asia said on Monday it has agreed to buy Japanese drugmaker Bushu Pharmaceuticals, valued at 77.3 billion yen ($668 million), from Tokio Marine Capital more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

BeiGene adds $75 million financing

November 17, 2014 : biotech, financing

BeiGene announced the successful completion of a financing of over 450 million RMB ($75 million USD) more »

Precision Therapeutics gains $60 million and new name, Helomics

November 17, 2014 : financing

Helomics announced the culmination of a recapitalization of the company more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Bayer hungry for pharma deals to expand business

October 31, 2014 : Bayer, big pharma, dealtalk, pharma deals

Big pharma company Bayer , is going hunting for pharma deals again, with its chief executive expected to tell media outlets  that it is looking for further takeover pharma deals.  more »

Equity firms eye Bayer’s plastic business merger

October 27, 2014 : Bayer, big pharma, business merger

Private equity firms are circling Bayer’s €10bn plastics business merger, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said yesterday. more »

 More dealtalk

Featured reports

Personalized Medicine Partnering Terms and Agreements

Publication date: November 2014

Companion Diagnostics Partnering Terms and Agreements

Publication date: November 2014

Pharmacogenomics Partnering Terms and Agreements

Publication date: November 2014

Option and Evaluation Partnering Terms and Agreements

Publication date: November 2014

Top 50 Big Pharma Partnering and M&A

Publication date: October 2014

Global Joint Venture Partnerships

Publication date: October 2014

Bioinformatics Partnering Terms and Agreements

Publication date: October 2014

Top 50 Big Biotech Partnering and M&A

Publication date: October 2014

Molecular Diagnostics Partnering Terms and Agreements

Publication date: October 2014

Regenerative Medicine Partnering Terms and Agreements

Publication date: October 2014

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports


Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:




Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
RSS Feed Linked In Twitter

Latest Tweets